Related Experiment Video
Updated: Jun 9, 2026

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
Published on: August 14, 2016
Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4
Shunbin Xiong1, Vinod Pant, Young-Ah Suh
1Departments of Genetics and Veterinary Medicine and Surgery, The University of Texas M.D. Anderson Cancer Center Houston, TX 77030, USA.
Abstract:
High levels of the critical p53 inhibitor Mdm4 is common in tumors that retain a wild-type p53 allele, suggesting that Mdm4 overexpression is an important mechanism for p53 inactivation during tumorigenesis. To test this hypothesis in vivo, we generated transgenic mice with widespread expression of Mdm4. Two independent lines of transgenic mice, Mdm4(Tg1) and Mdm4(Tg15), developed spontaneous tumors, the most prevalent of which were sarcomas. To determine whether overexpression of Mdm4 also cooperated with p53 heterozygosity to induce tumorigenesis, we generated Mdm4(Tg1) p53(+/-) mice. These mice had significantly accelerated tumorigenesis and a distinct tumor spectrum with more carcinomas and significantly fewer lymphomas than p53(+/-) or Mdm4(Tg1) mice. Importantly, the remaining wild-type p53 allele was retained in most Mdm4(Tg1) p53(+/-) tumors. Mdm4 is thus a bona fide oncogene in vivo and cooperates with p53 heterozygosity to drive tumorigenesis. These Mdm4 mice will be invaluable for in vivo drug studies of Mdm4 inhibitors.
Insights
Mdm4 protein overexpression drives tumor development in mice, acting as an oncogene. It also accelerates cancer when p53 is partially lost, highlighting Mdm4 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- High Mdm4 levels are observed in tumors with wild-type p53, suggesting Mdm4 inactivates p53 during cancer development.
- Mdm4 is a critical inhibitor of p53, a key tumor suppressor protein.
Purpose of the Study:
- To investigate the in vivo role of Mdm4 in tumorigenesis.
- To determine if Mdm4 overexpression cooperates with p53 heterozygosity in cancer induction.
Main Methods:
- Generated transgenic mice with widespread Mdm4 expression (Mdm4(Tg1) and Mdm4(Tg15) lines).
- Created Mdm4(Tg1) p53(+/-) mice to study the combined effects of Mdm4 overexpression and p53 heterozygosity.
- Analyzed tumor development, spectrum, and p53 allele status in generated mouse models.
Main Results:
- Mdm4 transgenic mice developed spontaneous tumors, primarily sarcomas.
- Mdm4(Tg1) p53(+/-) mice exhibited accelerated tumorigenesis compared to controls.
- Mdm4(Tg1) p53(+/-) mice showed a distinct tumor spectrum (more carcinomas, fewer lymphomas) with retention of the wild-type p53 allele in most tumors.
Conclusions:
- Mdm4 functions as a bona fide oncogene in vivo.
- Mdm4 cooperates with p53 heterozygosity to promote tumorigenesis.
- The generated Mdm4 mouse models are valuable for preclinical studies of Mdm4 inhibitors.
Related Concept Videos
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Induced Pluripotent Stem Cells
Somatic cells are...

